Showing posts with label flu and vaccinations. Show all posts
Showing posts with label flu and vaccinations. Show all posts

Sunday, April 21, 2024

Do you remember measles?

Let's celebrate the vibrant health and resilience of our communities! While it's true that the memories of diseases like measles have faded over the past few generations, it's essential to recognize the importance of vaccinations in preserving our well-being.

Measles, a once-common threat, has largely disappeared from our collective consciousness, thanks to the success of vaccines introduced in the 1960s. However, as we've seen in other parts of the world, complacency can lead to a resurgence of this highly contagious disease, with potentially severe consequences.

Measles, with its roots dating back thousands of years, has an extraordinary ability to infect and spread rapidly. Its impact extends beyond its immediate symptoms, affecting the immune system's memory and making individuals susceptible to other diseases. We've witnessed alarming rises in measles cases globally, with recent reports highlighting the importance of maintaining high vaccination coverage.

In the United States, where measles was once declared eradicated, they have experienced outbreaks linked to close-knit communities, emphasizing the need for widespread immunity. Even in Canada, a recent case underscores the potential risk of measles making a comeback. A 2022 study revealed that our measles immunity is below the 95 percent threshold required for sustained elimination, putting us at risk of outbreaks.

It's crucial to recognize the interconnectedness of health threats. While the focus may be on COVID-19, the resurgence of measles could amplify the challenges we face. Measles not only poses a direct threat but also erases immunity to previously contracted diseases, including COVID-19. This underlines the importance of maintaining a robust defence against infectious diseases.

We understand the concerns surrounding vaccines, especially amid the misinformation that has circulated during the pandemic. However, let's focus on solutions that benefit everyone. Ventilation and air filtration improvements in public spaces, workplaces, and classrooms can contribute significantly to reducing the risk of airborne diseases.

Clean air is a universally agreed-upon necessity. By investing in technologies that ensure the air we breathe is safe, we take a proactive step in safeguarding our health and preventing the resurgence of diseases like measles. Let's prioritize the well-being of our communities and work together to create environments that promote health, happiness, and longevity.

Stay well, stay informed, and let's build a future free from the threat of preventable diseases.

Thursday, February 8, 2024

How often should I be vaccinated?

 The recommended vaccination schedule for seniors can vary depending on the specific vaccine and individual circumstances. Here are the general guidelines for how often seniors should get these vaccinations:

Shingles (Shingrix):

Seniors should receive two doses of the Shingrix vaccine, with 2 to 6 months between doses. It is a one-time series, so you don't need to receive Shingrix repeatedly.

Pneumonia:

Prevnar 20 is a one-time vaccination for most seniors.

Pneumovax 23 should be given 8 weeks after the Prevnar 20 shot, and this combination is generally a one-time series.

Diphtheria, Tetanus, Pertussis (Tdap):

Seniors should receive a Tdap booster every 10 years to maintain protection against diphtheria, tetanus, and pertussis.

However, if you are in close contact with children under 4 years old (e.g., grandkids), you may need a Tdap booster to protect against pertussis even if it hasn't been a full 10 years.

RSV Vaccine:

The RSV vaccine is typically a one-time vaccination.

Influenza (High-Dose Quadrivalent Influenza Vaccine):

Seniors should receive the high-dose quadrivalent influenza vaccine annually, as the flu strains change each year.

It is important to get a flu shot each flu season to maintain protection.

It's important to note that these guidelines are general recommendations, and individual medical history and specific risk factors may influence a senior's vaccination schedule. It's always best to consult with a healthcare provider or primary care physician for personalized advice on when and which vaccines are appropriate for your specific health needs. Your healthcare provider can also help you keep track of your vaccination schedule and ensure you are up to date with the recommended vaccines for your age group.

Wednesday, February 7, 2024

Recommended Vaccine Information for Seniors Update:

The following is taken from an update by a friend of mine and I thank him for it. Please ensure that you talk to your medical advisor about your need for any vaccine. Do not take information from the Internet without checking with your medical provider. I am a big fan of vaccinations and recommend them to everyone I talk to or meet. These recommendations are from the National Advisory Council on Immunization for Canada,

Shingles:

Chickenpox vaccine (Varivax) is now a routine childhood immunization to prevent chickenpox. However, it is also recommended for adults who have never had chickenpox.

Shingrix is a highly effective vaccine offering robust protection against Shingles. It is administered in two doses, with a 2 to 6-month gap between them. The cost of Shingrix can vary; in British Columbia (BC), it is priced at $150-$165 per dose, while it may be available for free in other provinces. To determine the cost in your area, consult your medical provider.

Shingrix is approved and recommended for individuals aged 50 and older, even if they have previously received Zostavax. With an efficacy rate of approximately 95%, this vaccine provides long-lasting protection.

Pneumonia:

Pneumococcal Vaccination is crucial for protecting against diseases like pneumonia, bacteraemic pneumonia, sepsis, and meningitis caused by Streptococcus pneumoniae bacteria. Prevnar 20 is a new vaccine that covers 20 types of bacteria, replacing the previous Prevnar 13. In BC, it costs around $150. Please consult your medical provider for pricing information in other areas.

Pneumovax 23 is another important vaccine used to prevent pneumonia caused by 23 different types of pneumococci bacteria. It is publicly funded in BC but may incur costs in other jurisdictions. This vaccine offers protection against various diseases, from pneumonia to meningitis and severe bloodstream infections.

Diphtheria, Tetanus, Pertussis (Whooping Cough):

Diphtheria and Tetanus are severe infections caused by bacteria that produce toxins and can lead to serious health issues, including difficulty breathing, heart failure, and paralysis. Tetanus is often referred to as "lockjaw."

It is essential to receive the Tdap booster, a combination shot covering Diphtheria, Tetanus, and Pertussis, every 10 years. This booster is particularly important if you are in close contact with children under 4 years old, such as grandchildren. The cost of the Tdap booster can vary, so consult your medical provider for specific pricing information.

RSV Vaccine:

A respiratory syncytial virus (RSV) vaccine is available to protect against RSV infection. In British Columbia, this vaccine is priced between $230 and $250. Recently, it was announced that the RSV vaccine will be provided free of charge to individuals aged 65 and older in Ontario.

Influenza:

The High-Dose Quadrivalent Influenza Vaccine contains four times the antigen of a standard dose vaccine to account for age-related weakening of the immune system, known as "immunosenescence."

This vaccine, known as Fluzone High-Dose Quadrivalent Influenza Vaccine, costs approximately $90 in British Columbia. However, the cost may vary in other areas, so please check with your healthcare provider.

The High-Dose Quadrivalent Influenza Vaccine provides superior protection, offering more than 24% greater efficacy compared to the standard dose, with even better protection for individuals over the age of 65 and those with pre-existing chronic conditions.

The National Advisory Council on Immunization (NACI) recommends the High-Dose Quadrivalent Influenza Vaccine for adults aged 65 and older during the 2023/2024 flu season.